fbpx Skip to main content

WEDNESDAY, March 31, 2021 (HealthDay News) — Existing smokers or users of electronic nicotine delivery systems (ENDS) report increased use during the initial COVID-19 lockdown, according to a study published online March 1 in the International Journal of Drug Policy.

Daniel P. Giovenco, Ph.D., from Columbia University in New York City, and colleagues conducted semistructured telephone interviews with 44 adults who use cigarettes and/or ENDS.

The researchers found that nearly all participants reported changes in their product use during lockdown. Although patterns varied, increased use was the most common pattern and was predominantly driven by individual-level factors, including pandemic-related anxiety, boredom, and irregular routines. Social users reported decreased use, citing fewer interpersonal interactions and fear of sharing products. Cigarettes remained universally accessible, while ENDS access was more limited, driving some users to purchase products online. Some ENDS users reported compensating for delayed deliveries with readily available cigarettes.

“Pandemic response policies that intentionally or inadvertently restrict access to lower risk products — through availability, supply chains, or even postal service slowdowns — while leaving more harmful products widely accessible may have unintended consequences that should be considered during policy development,” Giovenco said in a statement.

Abstract/Full Text (subscription or payment may be required)

You May Also Like::  Pandemic Has Disrupted Lung Cancer Screenings

“Keeping up with the indications and adverse reactions to immune checkpoint inhibitors can be a full-time job. Cutaneous side effects occur in up to 45% of patients treated with ipilimumab and 34% of patients treated with nivolumab and pembrolizumab.” https://bit.ly/3FGtxtd

.@spfnomt: This month’s #DermWorld article “Estate planning 101” is especially important for young physicians to read. The long, all-consuming years between adolescence and physicianhood can become a blur...https://bit.ly/3FxOtCv

That’s a wrap #AAD2023! 5 days of soaking up knowledge from dermatologists on topics such as hidradenitis, melasma, & dietary triggers of common dermatoses.

I LOVED the #womenshealth focused sessions on vulvar dermatoses and pregnancy medication safety.


New approach uses microbiome to treat skin disease by repairing the injured microbiome that allowed inflammation to flare up in the first place, rather than reducing the inflammation after the fact. https://bit.ly/3Jt6H9v

Load More